Objective: To provide an overview of neuroleptic malignant syndrome (NMS) for the general
practitioner with the most up-to-date information on etiology, workup, and management …

Neuroleptic malignant syndrome (NMS) is a rare but potentially lethal form of drug-induced
hyperthermia characterised by mental status changes, muscle rigidity, hyperthermia and …

INTRODUCTION—Neuroleptic malignant syndrome (NMS) is a life-threatening neurologic
emergency associated with the use of antipsychotic (neuroleptic) agents and characterized …

The authors review the literature on persistent sequelae of neuroleptic malignant syndrome
(NMS). They highlight the clinical presentations, assessment, and management of persistent …

Purpose Neuroleptic malignant syndrome (NMS) is a rare and life threatening condition
usually defined as a complication of treatment with antipsychotics characterized by severe …

In recent years, there has been an increased use of neuroleptic agents in the primary care
setting. Neuroleptic malignant syndrome (NMS) is a rare complication of neuroleptic therapy …

Neuroleptic malignant syndrome (NMS) is an infrequent but potentially life-threatening
neurologic emergency. NMS first was described in association with the use of the …

Neuroleptic malignant syndrome (NMS) was first recognized as a life-threatening
complication of dopamine receptor antagonists characterized by extrapyramidal …

Neuroleptic malignant syndrome (NMS) is associated with the administration of
antipsychotic agents and other drugs such as l-dopa, antidepressants, and antihistaminic …

Abstract Neuroleptic Malignant Syndrome (NMS) is a life threatening complication of
antipsychotic therapy. It is often assumed to be rare. Observations suggest that rather than …